BELGIUM has advised against giving the Oxford/AstraZeneca vaccine to over-55s because of a lack of data about its efficacy.
It became the latest European Union country to recommend that the Covid jab should not be given to older people. Health minister Frank Vandenbroucke said the country’s advisory health council, had suggested the doses of the Oxford-produced vaccine should only be administered to people younger than 55. He said Belgium was reviewing its vaccination strategy because AstraZeneca’s jab was seen as a key part of the government’s plan to prioritise vulnerable groups.
TED (Tenders Electronic Daily) is the online version of the ‘Supplement to the Official Journal’ of the EU, dedicated to European public procurement.
The MHRA urgently seeks an Artificial Intelligence (AI) software tool to process the expected high volume of Covid-19 vaccine Adverse Drug Reaction (ADRs) and ensure that no details from the ADRs’ reaction text are missed.
ROADMAP ON VACCINATION
Last update: Q3 2019
Commission proposal for a common vaccination card/passport for EU citizens.
About 80% of patients have mild to moderate disease (including non-pneumonia and pneumonia cases), 13.8% have severe disease and 6.1% are critical (respiratory failure, septic shock, and/or multiple organ dysfunction/failure). Individuals at highest risk for severe disease and death are people aged over 60 years of age and those with underlying conditions such as hypertension, diabetes, cardiovascular disease, chronic respiratory disease and cancer. Disease in children appears to be relatively rare and mild. About 2.4% of the total reported cases were individuals under 19 years of age. A very small proportion of those aged under 19 years have developed severe (2.5%) or critical disease (0.2%).